{{Rsnum
|rsid=2267439
|Gene=SREBF2
|Chromosome=22
|position=41841765
|Orientation=plus
|GMAF=0.2897
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SREBF2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 34.5 | 58.4
| HCB | 20.4 | 55.5 | 24.1
| JPT | 7.2 | 46.8 | 45.9
| YRI | 0.0 | 29.3 | 70.7
| ASW | 8.8 | 24.6 | 66.7
| CHB | 20.4 | 55.5 | 24.1
| CHD | 23.4 | 56.1 | 20.6
| GIH | 5.9 | 28.7 | 65.3
| LWK | 5.5 | 26.6 | 67.9
| MEX | 1.8 | 30.4 | 67.9
| MKK | 1.9 | 22.6 | 75.5
| TSI | 11.8 | 43.1 | 45.1
| HapMapRevision=28
}}{{PMID|18954446|OA=1
}} avascular necrosis (AVN), a bone disease that produces osteonecrosis of the femoral head. The minor allele (C) frequency of rs2267439 showed a significant protective effect, while [[rs1052717]] and [[rs2267443]] were significantly associated with AVN risk

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}